Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome

Methods of inhibiting MASP-2-dependent complement activation in a subject suffering from catastrophic antiphospholipid syndrome

US Patent 11525011 · Granted Dec 13, 2022

Estimated economic value: $3,968,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of inhibiting MASP-2 for the treatment and/or prevention of coronavirus-2025
Anti-inflammatory and mydriatic intracameral solutions for inhibition of postope2024
Stable preservative-free mydriatic and anti-inflammatory solutions for injection2024
Therapeutic antibodies that bind to the serine protease domain of MASP-2 and use2024
Methods for inhibiting fibrosis in a subject in need thereof2024
Methods for inhibiting fibrosis in a subject in need thereof2024
Methods for inhibiting fibrosis in a subject in need thereof2024
Methods for inhibiting angiogenesis in a subject in need thereof2024
Methods for inhibiting angiogenesis in a subject in need thereof2024
Methods for inhibiting angiogenesis in a subject in need thereof2024
Methods for treating conditions associated with MASP-2 dependent complement acti2024
Methods for treating conditions associated with MASP-2 dependent complement acti2024